Patients should maintain adequate fibre intake during remission, though this may need modification during flares
For detailed steps, refer to the full Instructions for Use here
Last week in Seattle, researchers from Massachusetts Eye and Ear as well as Havard Medical School presented their findings at ARVO 2024 that highlighted the link between prescribed GLP-1 inhibitors and the development of vision loss due to NAION
The choice of alternative therapy depends on individual patient factors including renal function, cardiovascular risk profile, weight management goals, hypoglycaemia risk, and patient preferences, all of which should be discussed thoroughly with the GP or diabetes specialist team
The Framingham Offspring Study
Clinical trial enrollment (free, pharmaceutical-grade) The best option for retatrutide access